|
PSA (ng/ml)
|
Prostate cancer detection rate (%) (no./total no.)
|
|---|
|
≤ 50 years
|
51–60 years
|
61–70 years
|
71–80 years
|
> 80 years
|
|---|
|
0–4
|
100 (1/1)
|
33.3 (3/9)
|
21.9 (7/32)
|
31.8 (7/22)
|
50 (3/6)
|
|
4–10
|
0 (0/7)
|
10.8 (4/37)
|
16.7 (17/102)
|
28.8 (30/104)
|
50 (10/20)
|
|
10–20
|
0 (0/6)
|
23.1 (9/39)
|
30.6 (33/108)
|
40.1 (55/137)
|
50 (26/52)
|
|
20–100
|
0 (0/0)
|
55.6 (10/18)
|
47.7 (31/65)
|
61.5 (72/117)
|
70.2 (33/47)
|
|
≥ 100
|
0 (0/0)
|
100 (4/4)
|
88.5 (23/26)
|
95.6 (43/45)
|
94.4 (17/18)
|
|
Total
|
7.1 (1/14)
|
28.1(30/107)
|
33.3 (111/333)
|
48.7 (207/425)
|
62.2 (89/143)
|
-
PSA prostatic-specific antigen
